Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis.

Multiple sclerosis and related disorders·2024
Same author

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study.

Journal of neurology·2023
Same author

What women emphasise as important aspects of care in childbirth - an online survey.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Multiple sclerosis registries in Europe - An updated mapping survey.

Multiple sclerosis and related disorders·2018
Same author

Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report.

Journal of the neurological sciences·2016
Same author

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.

Acta neurologica Scandinavica·2015

Related Experiment Video

Updated: May 15, 2026

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.

A C Kroksveen1, A Guldbrandsen, C Vedeler

  • 1The KG Jebsen Centre for MS-research, Department of Clinical Medicine, University of Bergen, Bergen, Norway. ann.kroksveen@med.uib.no

Acta Neurologica Scandinavica. Supplementum
|January 3, 2013
PubMed
Summary

Researchers identified 32 significantly different proteins in cerebrospinal fluid (CSF) between relapsing-remitting multiple sclerosis (RRMS) patients and controls. These proteins may serve as diagnostic biomarkers for RRMS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Related Experiment Videos

Last Updated: May 15, 2026

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid
10:23

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

Published on: December 4, 2017

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Area of Science:

  • Proteomics
  • Neuroimmunology
  • Biomarker Discovery

Background:

  • Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Relapsing-remitting MS (RRMS) is the most common form, characterized by distinct attacks and remissions.
  • Identifying reliable biomarkers for RRMS is crucial for diagnosis and understanding disease pathogenesis.

Purpose of the Study:

  • To identify proteins with differential abundance in cerebrospinal fluid (CSF) between RRMS patients and healthy controls.
  • To discover potential diagnostic biomarkers for RRMS.
  • To gain insights into the molecular mechanisms underlying RRMS pathogenesis.

Main Methods:

  • Cerebrospinal fluid (CSF) samples from 17 RRMS patients and 17 controls were analyzed.
  • Proteins were digested and analyzed using label-free liquid chromatography-mass spectrometry (LC-MS).
  • Data analysis was performed using SearchGUI, PeptideShaker, and Progenesis software.

Main Results:

  • A total of 291 proteins were identified in the CSF.
  • 32 proteins showed significant differential abundance (P ≤ 0.05) between RRMS patients and controls.
  • Included proteins previously associated with MS, such as immunoglobulin subunits and vitamin D-binding protein.

Conclusions:

  • The study identified several differentially abundant proteins in the CSF of RRMS patients.
  • These proteins represent potential biomarkers for RRMS diagnosis and therapeutic targets.
  • Further validation in larger cohorts is necessary to confirm their clinical utility and role in disease pathogenesis.